ImmunoPrecise Antibodies Ltd (IPA)
1.31
-0.06
(-4.38%)
USD |
NASDAQ |
Apr 30, 11:24
ImmunoPrecise Antibodies Market Cap: 34.47M for April 30, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 29, 2024 | 36.05M |
| April 26, 2024 | 34.74M |
| April 25, 2024 | 31.42M |
| April 24, 2024 | 32.10M |
| April 23, 2024 | 32.10M |
| April 22, 2024 | 32.89M |
| April 19, 2024 | 33.16M |
| April 18, 2024 | 32.63M |
| April 17, 2024 | 33.42M |
| April 16, 2024 | 33.95M |
| April 15, 2024 | 32.63M |
| April 12, 2024 | 35.79M |
| April 11, 2024 | 36.05M |
| April 10, 2024 | 36.58M |
| April 09, 2024 | 36.32M |
| April 08, 2024 | 37.37M |
| April 05, 2024 | 37.89M |
| April 04, 2024 | 38.16M |
| April 03, 2024 | 38.16M |
| April 02, 2024 | 38.68M |
| April 01, 2024 | 40.26M |
| March 28, 2024 | 40.00M |
| March 27, 2024 | 41.32M |
| March 26, 2024 | 40.00M |
| March 25, 2024 | 40.00M |
| Date | Value |
|---|---|
| March 22, 2024 | 41.32M |
| March 21, 2024 | 36.84M |
| March 20, 2024 | 37.10M |
| March 19, 2024 | 38.16M |
| March 18, 2024 | 36.84M |
| March 15, 2024 | 37.89M |
| March 14, 2024 | 41.84M |
| March 13, 2024 | 42.89M |
| March 12, 2024 | 43.16M |
| March 11, 2024 | 46.05M |
| March 08, 2024 | 48.42M |
| March 07, 2024 | 48.42M |
| March 06, 2024 | 41.58M |
| March 05, 2024 | 42.89M |
| March 04, 2024 | 46.58M |
| March 01, 2024 | 49.47M |
| February 29, 2024 | 48.55M |
| February 28, 2024 | 47.63M |
| February 27, 2024 | 48.95M |
| February 26, 2024 | 48.95M |
| February 23, 2024 | 50.00M |
| February 22, 2024 | 45.26M |
| February 21, 2024 | 45.26M |
| February 20, 2024 | 48.95M |
| February 16, 2024 | 51.84M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
18.77M
Minimum
Feb 20 2020
314.32M
Maximum
Dec 29 2020
92.97M
Average
91.84M
Median
Market Cap Benchmarks
| Acasti Pharma Inc | 28.67M |
| Aurinia Pharmaceuticals Inc | 735.38M |
| Edesa Biotech Inc | 13.86M |
| Lexaria Bioscience Corp | 36.72M |
| Xenon Pharmaceuticals Inc | 3.176B |
Market Cap Related Metrics
| PS Ratio | 1.885 |
| Price to Book Value | 0.9274 |
| Price | 1.31 |
| Earnings Yield | -31.66% |